Now volatility is end to end, and supply chain planning extends beyond order fulfillment to sustainability and resiliency. The good news: They’ve updated the operator’s manual.

In just a decade, Mexican manufacturing has experienced a seismic shift, driven by the swift rise in automation, a notable influx of Chinese enterprises, and substantial diversification across industries.

It’s no wonder that companies from all over the world are establishing operations in Mexico.

Congress is finally acting to address the severe shortage of critical pharmaceutical drugs, a crisis long in the making that was laid bare by the COVID-19 pandemic.

Biocair, a courier service specializing in serving biotechnology providers, seeks the latest technology for monitoring and visibility of cell and gene-therapy shipments.

While rates of HIV have been declining, other sexually transmitted diseases have become more prevalent in recent years.

The Medical Supply Chain Resiliency Act would allow the establishment of trusted trade partnerships to diversify the sourcing and procurement of medical devices as well as pharmaceuticals.

The pharmaceutical industry has an opportunity to move production onshore. It should take it.

Medical supply chains are experiencing a "severe" shortage of cancer drugs after carboplatin and cisplatin were reportedly found to be in “extremely short supply.”

The trend comes in part from the U.S.-Mexico-Canada Agreement (USMCA), which took effect in July 2020 as a replacement for the North American Free Trade Agreement.